Raymond James & Associates’s Enovix ENVX Stock Holding History

Raymond James & Associates’s Portfolio ENVX Stock Details ENVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$2.77M	Sell	339,015 -153,242	-31%	-$1.59M	﹤0.01%	2018
2024 Q2	$6.66M	Sell	492,257 -13,838	-3%	-$116K	﹤0.01%	1394
2024 Q1	$3.55M	Buy	506,095 +23,166	+5%	+$201K	﹤0.01%	1807
2023 Q4	$5.29M	Buy	482,929 +32,191	+7%	+$316K	﹤0.01%	1502
2023 Q3	$4.95M	Buy	450,738 +191,596	+74%	+$2.74M	﹤0.01%	1460
2023 Q2	$4.09M	Buy	259,142 +192,987	+292%	+$2.25M	﹤0.01%	1616
2023 Q1	$863K	Buy	66,155 +41,656	+170%	+$342K	﹤0.01%	2540
2022 Q4	$267K	Buy	24,499 +2,528	+12%	+$31.1K	﹤0.01%	3287
2022 Q3	$352K	Buy	+21,971	New	+$324K	﹤0.01%	3077

Other funds holding ENVX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ECP

Electron Capital Partners New York $2.55B AUM 87.77% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Raymond James & Associates's ENVX Position: Q3 2024 in Review

Raymond James & Associates reduced its Enovix (ENVX) stake by 31% in Q3 2024, selling an estimated $1.59M and leaving 339,015 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2018.

Raymond James & Associates first reported a position in ENVX in Q3 2022 and has held it in 9 quarters since. The position peaked at $6.66M in Q2 2024. 288 funds tracked by Wall St. Rank hold ENVX as of Q3 2024.

Raymond James & Associates held 339,015 shares of Enovix worth $2.77M as of Q3 2024.
Raymond James & Associates sold 153,242 Enovix shares in Q3 2024, an estimated $1.59M.
Enovix made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2018 holding.
Raymond James & Associates first reported a position in Enovix in Q3 2022 and has held it in 9 quarters since.
Raymond James & Associates's Enovix position peaked at $6.66M in Q2 2024.
288 funds tracked by Wall St. Rank held Enovix as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.